12-Lipoxygenase
ALOX12gene12-LOX catalyzes arachidonic acid metabolism toward pro-thrombotic lipid mediators that amplify platelet response.
Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencemedium
RationaleProthrombotic lipid metabolism enzyme driving platelet activation.
Also acts inThromboxane / COX-1, Vascular inflammation, Myocardial injury
Druggability
DruggableYes
Known drugs / candidates1
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000108839
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I55
C — confounder / Type-II59
A — assay feasibility52
E — evidence strength24
T1DI (composite)6
Specificity differential (R−C)-4.2
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(2)
- The potential effective components from Danlou tablet attenuates acute myocardial infarction by restoring ALOX12-mediated perturbed oxylipins.Journal of ethnopharmacology · 2025 · PMID 40086610 · doi
- Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation.Blood · 2022 · PMID 34905596 · doi